Scientists test new Drug's impact on common sedative
NCT ID NCT05550636
Summary
This early-stage study aimed to understand how taking multiple doses of a new drug, BI 1015550, affects how the body processes a common sedative called midazolam. It involved 15 healthy male volunteers who took both drugs in a specific sequence. The goal was to gather safety data and see if the new drug changes how quickly the sedative leaves the body, which is important for future patient use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.